
Vol. 69, No. 4, 2005
Free Abstract
Article (Fulltext)
Article (PDF 159 KB)
Review
Present Status and Perspectives in the Treatment of Hormone-Refractory Prostate Cancer
Nicola Silvestrisa, Bernardo Leonee, Gianmauro Numicob, Vito Lorussoc, Mario De Lenad
Operative Units of Medical Oncology, aOncology Center Giorgio Porfiri, Latina, bSanta Croce e Carle General Hospital, Cuneo, cOncology Institute, Bari, and dScientific Direction, Oncology Institute, Bari, Italy; eGrupo Oncologico Cooperativo del Sur, Neuquén, Argentina
Address of Corresponding Author
Oncology 2005;69:273-282 (DOI: 10.1159/000089676)
Key Words
- Androgen deprivation
- Chemotherapy
- Hormone-refractory cancer
- Prostate cancer
- Radiotherapy
Abstract
The cornerstone in the treatment of de novo or recurrent metastatic prostate cancer is androgen deprivation. Unfortunately, nearly all patients will develop androgen-independent ('hormone-refractory') disease with progressive clinical deterioration and ultimately death. Chemotherapy has been shown to palliate symptoms of hormone-refractory disease but not to improve survival. Recently, two large phase III trials have demonstrated an overall survival advantage for patients treated with docetaxel-based regimens as compared to the best standard of care. Indeed, investigations into the pathophysiology of this malignancy, novel biological agents, skeletal protectants and radiopharmaceuticals are expanding the clinician's armamentarium and improving the patient's outcome. Copyright © 2005 S. Karger AG, Basel
Author Contacts
Mario De Lena, MD Oncology Institute Via Amendola 209 IT-70126 Bari (Italy) Tel. +39 080 5555471, E-Mail mariodelena@yahoo.com
Article Information
Received: January 4, 2005
Accepted after revision: April 29, 2005
Published online: November 9, 2005
Number of Print Pages : 10
Number of Figures : 0, Number of Tables : 4, Number of References : 77 |
|

|

For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service. |
|
|